Bioalpha Holdings Bhd (0179) - Net Assets
Based on the latest financial reports, Bioalpha Holdings Bhd (0179) has net assets worth RM69.43 Million MYR (≈ $17.43 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM79.15 Million ≈ $19.87 Million USD) and total liabilities (RM9.72 Million ≈ $2.44 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Bioalpha Holdings Bhd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM69.43 Million |
| % of Total Assets | 87.72% |
| Annual Growth Rate | -1.28% |
| 5-Year Change | -62.81% |
| 10-Year Change | -29.15% |
| Growth Volatility | 21.57 |
Bioalpha Holdings Bhd - Net Assets Trend (2015–2025)
This chart illustrates how Bioalpha Holdings Bhd's net assets have evolved over time, based on quarterly financial data. Also explore how large is Bioalpha Holdings Bhd's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Bioalpha Holdings Bhd (2015–2025)
The table below shows the annual net assets of Bioalpha Holdings Bhd from 2015 to 2025. For live valuation and market cap data, see 0179 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | RM69.43 Million ≈ $17.43 Million |
-29.40% |
| 2024-12-31 | RM98.34 Million ≈ $24.69 Million |
-22.79% |
| 2023-12-31 | RM127.37 Million ≈ $31.98 Million |
-24.12% |
| 2022-12-31 | RM167.86 Million ≈ $42.14 Million |
-10.08% |
| 2021-12-31 | RM186.67 Million ≈ $46.87 Million |
+16.02% |
| 2020-12-31 | RM160.90 Million ≈ $40.40 Million |
-2.81% |
| 2019-12-31 | RM165.55 Million ≈ $41.56 Million |
+5.03% |
| 2018-12-31 | RM157.62 Million ≈ $39.57 Million |
+16.38% |
| 2017-12-31 | RM135.44 Million ≈ $34.00 Million |
+38.21% |
| 2016-12-31 | RM97.99 Million ≈ $24.60 Million |
+24.03% |
| 2015-12-31 | RM79.00 Million ≈ $19.84 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Bioalpha Holdings Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 130.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | RM76.19 Million | 109.74% |
| Other Components | RM2.89 Million | 4.16% |
| Total Equity | RM69.43 Million | 100.00% |
Bioalpha Holdings Bhd Competitors by Market Cap
The table below lists competitors of Bioalpha Holdings Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
D.T.C. Industries Public Company Limited
BK:DTCI
|
$5.30 Million |
|
Chiangmai Rimdoi Public Company Limited
BK:CRD
|
$5.30 Million |
|
Archies Limited
NSE:ARCHIES
|
$5.30 Million |
|
Nobel29 Resources Corp
V:NBLC
|
$5.30 Million |
|
Aptorum Group Ltd Class A
NASDAQ:APM
|
$5.30 Million |
|
Sungshin Cement Co Ltd
KO:004985
|
$5.29 Million |
|
Global Interactive Technologies, Inc
NASDAQ:GITS
|
$5.29 Million |
|
East Side Games Group Inc
TO:EAGR
|
$5.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bioalpha Holdings Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 98,344,030 to 69,429,000, a change of -28,915,030 (-29.4%).
- Net loss of 29,600,000 reduced equity.
- Other factors increased equity by 881,970.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM-29.60 Million | -42.63% |
| Other Changes | RM881.97K | +1.27% |
| Total Change | RM- | -29.40% |
Book Value vs Market Value Analysis
This analysis compares Bioalpha Holdings Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.30x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.10x to 0.30x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM0.15 | RM0.02 | x |
| 2017-12-31 | RM0.17 | RM0.02 | x |
| 2018-12-31 | RM0.18 | RM0.02 | x |
| 2019-12-31 | RM0.19 | RM0.02 | x |
| 2020-12-31 | RM0.14 | RM0.02 | x |
| 2021-12-31 | RM0.16 | RM0.02 | x |
| 2022-12-31 | RM0.12 | RM0.02 | x |
| 2023-12-31 | RM0.09 | RM0.02 | x |
| 2024-12-31 | RM0.07 | RM0.02 | x |
| 2025-12-31 | RM0.05 | RM0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bioalpha Holdings Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -42.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -257.77%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 1.14x
- Recent ROE (-42.63%) is below the historical average (-13.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 8.60% | 22.87% | 0.34x | 1.12x | RM-1.10 Million |
| 2016 | 8.66% | 18.01% | 0.41x | 1.16x | RM-1.31 Million |
| 2017 | 5.81% | 14.07% | 0.36x | 1.14x | RM-5.68 Million |
| 2018 | 7.34% | 16.51% | 0.39x | 1.14x | RM-4.19 Million |
| 2019 | 5.02% | 13.06% | 0.33x | 1.17x | RM-8.24 Million |
| 2020 | -25.57% | -112.85% | 0.19x | 1.16x | RM-57.24 Million |
| 2021 | -0.69% | -1.33% | 0.44x | 1.16x | RM-19.95 Million |
| 2022 | -28.49% | -133.62% | 0.18x | 1.20x | RM-64.62 Million |
| 2023 | -32.98% | -91.13% | 0.28x | 1.28x | RM-54.74 Million |
| 2024 | -49.37% | -78.28% | 0.52x | 1.21x | RM-58.39 Million |
| 2025 | -42.63% | -257.77% | 0.15x | 1.14x | RM-36.54 Million |
Industry Comparison
This section compares Bioalpha Holdings Bhd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $801,466,200
- Average return on equity (ROE) among peers: 19.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bioalpha Holdings Bhd (0179) | RM69.43 Million | 8.60% | 0.14x | $5.30 Million |
| Three A Resources Bhd (0012) | $348.17 Million | 8.45% | 0.17x | $86.02 Million |
| Sunzen Biotech Bhd (0148) | $97.23 Million | -0.13% | 0.09x | $45.14 Million |
| Nova Wellness Group Bhd (0201) | $109.78 Million | 7.17% | 0.09x | $27.21 Million |
| SDS Group Bhd (0212) | $71.91 Million | 10.11% | 0.93x | $60.59 Million |
| PTRB (0260) | $209.41 Million | 5.85% | 0.79x | $39.63 Million |
| MYMBN Berhad (0280) | $10.79 Million | 62.41% | 0.50x | $9.21 Million |
| SBH Marine Holdings Berhad (0300) | $73.93 Million | 17.64% | 0.36x | $32.33 Million |
| OB Holdings Berhad (0327) | $58.86 Million | 9.34% | 0.34x | $20.16 Million |
| IOI Corporation Bhd (1961) | $6.23 Billion | 54.11% | 1.46x | $6.38 Billion |
About Bioalpha Holdings Bhd
Bioalpha Holdings Berhad, an investment holding company, manufactures and sells health supplement products in Malaysia, China, and internationally. It operates through Trading and Manufacturing segments. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export… Read more